<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">anhydrase </span>
   <span class="font30">carbonic </span>
   <span class="font24">cancer </span>
   <span class="font23">cells </span>
   <span class="font23">tumour </span>
   <span class="font20">Med </span>
   <span class="font19">circulating </span>
   <span class="font19">Chem;:–. </span>
   <span class="font18">{border-style </span>
   <span class="font17">biopsy </span>
   <span class="font17">px;} </span>
   <span class="font17">#ffffff;} </span>
   <span class="font17">cell </span>
   <span class="font16">cancer. </span>
   <span class="font16">liquid </span>
   <span class="font15">CTCs </span>
   <span class="font15">tumor </span>
   <span class="font14">DNA </span>
   <span class="font14">activity </span>
   <span class="font14">anhydrases </span>
   <span class="font14">role </span>
   <span class="font14">Enzyme </span>
   <span class="font14">cells. </span>
   <span class="font14">exosomes </span>
   <span class="font14">expression </span>
   <span class="font14">inhibitors </span>
   <span class="font14">metastatic </span>
   <span class="font14">patients </span>
   <span class="font13">Inhib </span>
   <span class="font13">biomarker </span>
   <span class="font13">body </span>
   <span class="font13">inhibition </span>
   <span class="font13">CapassoC, </span>
   <span class="font13">Curr </span>
   <span class="font13">Opin </span>
   <span class="font13">al.Carbonic </span>
   <span class="font13">extracellular </span>
   <span class="font13">new </span>
   <span class="font13">px; </span>
   <span class="font13">released </span>
   <span class="font13">renal </span>
   <span class="font13">tumours </span>
   <span class="font13">{font-family </span>
   <span class="font13">Bioorg </span>
   <span class="font13">Expert </span>
   <span class="font13">SupuranCT, </span>
   <span class="font13">SupuranCTCarbonic </span>
   <span class="font13">blood </span>
   <span class="font13">detection </span>
   <span class="font13">font-size </span>
   <span class="font13">growth </span>
   <span class="font13">level </span>
   <span class="font13">protein </span>
   <span class="font13">types </span>
   <span class="font13">used </span>
   <span class="font13">vesicles </span>
   <span class="font12">(CA </span>
   <span class="font12">Mol </span>
   <span class="font12">Moreover, </span>
   <span class="font12">active </span>
   <span class="font12">biomarkers </span>
   <span class="font12">double; </span>
   <span class="font12">enzyme </span>
   <span class="font12">exosomal </span>
   <span class="font12">levels </span>
   <span class="font12">primary </span>
   <span class="font12">treatment </span>
   <span class="font12">Biol </span>
   <span class="font12">Liquid </span>
   <span class="font12">Ther </span>
   <span class="font12">anhydrases. </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">breast </span>
   <span class="font12">carcinoma </span>
   <span class="font12">different </span>
   <span class="font12">drug </span>
   <span class="font12">early </span>
   <span class="font12">genomic </span>
   <span class="font12">healthy </span>
   <span class="font12">hypoxia </span>
   <span class="font12">increased </span>
   <span class="font12">information </span>
   <span class="font12">invasion </span>
   <span class="font12">investigated </span>
   <span class="font12">non-invasive </span>
   <span class="font12">novel </span>
   <span class="font12">number </span>
   <span class="font12">overview </span>
   <span class="font12">serum </span>
   <span class="font12">solid; </span>
   <span class="font12">studies </span>
   <span class="font12">therapeutic </span>
   <span class="font12">tumour-associated </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">Besides, </span>
   <span class="font11">Biophys </span>
   <span class="font11">CTCs. </span>
   <span class="font11">Cancer;:–. </span>
   <span class="font11">EVs </span>
   <span class="font11">Int </span>
   <span class="font11">Lett;:–. </span>
   <span class="font11">SimoneG, </span>
   <span class="font11">al.Circulating </span>
   <span class="font11">antitumor </span>
   <span class="font11">based </span>
   <span class="font11">bold </span>
   <span class="font11">cells, </span>
   <span class="font11">characterization </span>
   <span class="font11">considered </span>
   <span class="font11">correlated </span>
   <span class="font11">courier; </span>
   <span class="font11">ctDNA </span>
   <span class="font11">em; </span>
   <span class="font11">example, </span>
   <span class="font11">fluids </span>
   <span class="font11">form </span>
   <span class="font11">higher </span>
   <span class="font11">inhibitors: </span>
   <span class="font11">isoform </span>
   <span class="font11">lung </span>
   <span class="font11">markers </span>
   <span class="font11">microenvironment </span>
   <span class="font11">patient </span>
   <span class="font11">potential </span>
   <span class="font11">process. </span>
   <span class="font11">pt;} </span>
   <span class="font11">relationship </span>
   <span class="font11">release </span>
   <span class="font11">target </span>
   <span class="font11">tissue </span>
   <span class="font11">using </span>
  </p>
 </body>
</html>
